FDA Inspection
Lydie L. Hazan, M.D.Lydie L. Hazan, M.D. – FDA Inspection, Feb 11, 2010
Record Details
This FDA Inspection record concerns Lydie L. Hazan, M.D., with an inspection on February 11, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lydie L. Hazan, M.D.
- Inspection Date
- February 11, 2010
- Product Type
- Drugs
View Company Profile
ID · 87b521a3-5ab8-4e23-9e72-0471d9735b9a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 645552
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60Informed consent
- 21 CFR 50.20Understandable language
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lydie L. Hazan, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 23, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 25, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 19, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 26, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Lydie L. Hazan, M.D.
- FDA Inspection 1132614 - 2020-10-23
- FDA Inspection 914152 - 2015-02-25
- FDA Inspection 801048 - 2012-09-19
- FDA Inspection 658026 - 2010-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.